Shionogi plans global expansion of R&D operations

Japanese pharma major Shionogi (TYO: 4507) says it is responding to the urgent global need for additional antimicrobial research and development by establishing its first discovery laboratory in San Diego, California, USA.

Shionogi, whose shares edged up 1.3% to7,208 yen on the news, made the announcement during a panel discussion at trade group BIO that convened top industry and public health leaders from the White House Office of Pandemic Preparedness and Response Policy; the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) at the US Department of Health and Human Services (HHS); and the Center for Infectious Disease Research and Policy (CIDRAP).

Qpex Biopharma to get new state-if-the-art lab